Sanicka Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Sanicka General Information
Description
Developer of a precision medicine support tool designed for leukemia treatment. The company uses patient and tumor-specific data to simulate the response to different treatment alternatives, providing dynamic predictions of the tumor response and patient recovery before, during, and after therapy, enabling healthcare organizations to provide personalized leukemia treatment and improve patient outcomes.
Contact Information
Website
www.sanicka.comCorporate Office
- 1910 Durand
- Mill Drive Northeast
- Atlanta, GA 30307-1173
- United States
Corporate Office
- 1910 Durand
- Mill Drive Northeast
- Atlanta, GA 30307-1173
- United States
Sanicka Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 23-Jul-2026 | Completed | Out of Business | |||
| 3. Early Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Sanicka FAQs
-
When was Sanicka founded?
Sanicka was founded in 2021.
-
Where is Sanicka headquartered?
Sanicka is headquartered in Atlanta, GA.
-
What industry is Sanicka in?
Sanicka’s primary industry is Decision/Risk Analysis.
-
Is Sanicka a private or public company?
Sanicka is a Private company.
-
What is Sanicka’s current revenue?
The current revenue for Sanicka is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process